Published in Mech Dev on February 01, 1996
The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol (1999) 3.70
Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J (1998) 3.27
A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration. EMBO J (2002) 1.13
A distal Schwann cell-specific enhancer mediates axonal regulation of the Oct-6 transcription factor during peripheral nerve development and regeneration. EMBO J (2000) 1.01
The transcription factor Pou3f1 promotes neural fate commitment via activation of neural lineage genes and inhibition of external signaling pathways. Elife (2014) 0.88
Gbx2 directly restricts Otx2 expression to forebrain and midbrain, competing with class III POU factors. Mol Cell Biol (2012) 0.82
Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression. BMC Psychiatry (2005) 0.79
Neurological disturbances, premature lethality, and central myelination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6. J Clin Invest (1998) 0.79
Octamer-binding factor 6 (Oct-6/Pou3f1) is induced by interferon and contributes to dsRNA-mediated transcriptional responses. BMC Cell Biol (2010) 0.78
Genome-Wide Definition of Promoter and Enhancer Usage during Neural Induction of Human Embryonic Stem Cells. PLoS One (2015) 0.76
Dysregulation of the SIRT1/OCT6 Axis Contributes to Environmental Stress-Induced Neural Induction Defects. Stem Cell Reports (2017) 0.75
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell (1997) 12.41
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell (1996) 9.74
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell (1984) 6.78
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature (1996) 6.17
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1982) 5.95
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell (1998) 5.92
Jak2 is essential for signaling through a variety of cytokine receptors. Cell (1998) 5.92
The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J (1997) 4.65
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature (1984) 4.30
Structural organization of the bcr gene and its role in the Ph' translocation. Nature (1985) 4.08
Comparison of cloned rabbit and mouse beta-globin genes showing strong evolutionary divergence of two homologous pairs of introns. Nature (1978) 3.86
Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1984) 3.24
The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol (1992) 3.12
Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene. Mol Cell Biol (1992) 2.99
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia (1995) 2.54
Translocation of oncogene c-sis from chromosome 22 to chromosome 11 in a Ewing sarcoma-derived cell line. Mol Cell Biol (1985) 2.45
Regional mapping of the human immunoglobulin lambda light chain to the Philadelphia chromosome in chronic myeloid leukaemia. Leuk Res (1984) 2.44
Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. Proc Natl Acad Sci U S A (1995) 2.29
Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell (1987) 2.27
The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes. J Cell Biol (2000) 2.26
The POU factor Oct-6 and Schwann cell differentiation. Science (1996) 2.17
G2 arrest and impaired nucleocytoplasmic transport in mouse embryos lacking the proto-oncogene CAN/Nup214. EMBO J (1996) 2.17
The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J (1999) 2.13
The structure of a human neurofilament gene (NF-L): a unique exon-intron organization in the intermediate filament gene family. Biochim Biophys Acta (1987) 2.10
The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells. Nucleic Acids Res (1990) 1.81
Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. Blood (1990) 1.78
Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene (1995) 1.78
The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol (1996) 1.75
The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. Mol Cell Biol (1986) 1.72
Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N Engl J Med (1985) 1.61
DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer. Proc Natl Acad Sci U S A (1997) 1.46
Ultrasonic dissection for endoscopic surgery. The E.A.E.S. Technology Group. Surg Endosc (1999) 1.42
INK4d-deficient mice are fertile despite testicular atrophy. Mol Cell Biol (2000) 1.40
Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev (1996) 1.39
Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther (1995) 1.37
Evolution and mutagenesis of the mammalian excision repair gene ERCC-1. Nucleic Acids Res (1988) 1.34
Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. Oncogene (1996) 1.34
Molecular characterization of the testis specific c-abl mRNA in mouse. EMBO J (1987) 1.31
A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia (1990) 1.30
The binding of activated C3 to polysaccharides and immunoglobulins. J Immunol (1978) 1.29
The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol Cell Biol (1990) 1.27
Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol Cell Biol (1998) 1.24
Mapping the transactivation domain of the Oct-6 POU transcription factor. Nucleic Acids Res (1992) 1.21
Dietzia natronolimnaios sp. nov., a new member of the genus Dietzia isolated from an east African soda lake. Extremophiles (1998) 1.19
c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. J Exp Med (1983) 1.19
Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosomes Cancer (1992) 1.18
Comparison of the human and mouse PIM-1 cDNAs: nucleotide sequence and immunological identification of the in vitro synthesized PIM-1 protein. Oncogene Res (1987) 1.14
bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient. Leukemia (1991) 1.10
Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene. Baillieres Clin Haematol (1992) 1.09
Mouse "protective protein". cDNA cloning, sequence comparison, and expression. J Biol Chem (1990) 1.09
Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3. J Neurosci Res (1996) 1.09
C-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J (1985) 1.08
Construction of stabilized proteins by combinatorial consensus mutagenesis. Protein Eng Des Sel (2004) 1.07
Cloning a cDNA for the lysosomal alpha-glucosidase. Biochem Biophys Res Commun (1984) 1.06
Molecular analysis of both translocation products of a Philadelphia-positive CML patient. Nucleic Acids Res (1986) 1.05
TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol (1997) 1.04
Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization. Blood (1984) 1.04
The human pim-1 gene is not directly activated by the translocation (6;9) in acute nonlymphocytic leukemia. Oncogene (1989) 1.03
The mouse low density lipoprotein receptor gene: cDNA sequence and exon-intron structure. Biochem Biophys Res Commun (1993) 1.03
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance. Ann Oncol (2011) 1.02
bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia (1988) 1.02
A distal Schwann cell-specific enhancer mediates axonal regulation of the Oct-6 transcription factor during peripheral nerve development and regeneration. EMBO J (2000) 1.01
Role of Oct-6 in Schwann cell differentiation. Microsc Res Tech (1998) 0.99
Comparison of sequence and function of the Oct-6 genes in zebrafish, chicken and mouse. Mech Dev (1998) 0.97
COX-2 expression in chondrosarcoma: a role for celecoxib treatment? Eur J Cancer (2009) 0.96
Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer (1993) 0.95
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice. Leukemia (2000) 0.93
Yeast artificial chromosome targeting technology: an approach for the deletion of genes in the C57BL/6 mouse. Anal Biochem (2001) 0.92
Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. Blood (1984) 0.92
Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. Leukemia (2004) 0.91
Cloning and expression of an endocellulase gene from a novel streptomycete isolated from an East African soda lake. Extremophiles (2001) 0.91
Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia. J Exp Med (1989) 0.90
The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood (1992) 0.90
Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer. Br J Cancer (2010) 0.87
Chromosomal localization of genes encoding CAN/Nup214-interacting proteins--human CRM1 localizes to 2p16, whereas Nup88 localizes to 17p13 and is physically linked to SF2p32. Genomics (1997) 0.86
Regulation of human globin gene switching. Cold Spring Harb Symp Quant Biol (1993) 0.86
[Laparoscopic splenectomy revisited]. Ann Chir (1995) 0.86
Characterization of the translocation breakpoint in a patient with Philadelphia positive, bcr negative acute lymphoblastic leukaemia. Oncogene (1988) 0.84
HLA-DR genotyping by restriction fragment length polymorphism analyses. Immunogenetics (1985) 0.82
Genetic variability of the murine creatine kinase B gene locus and related pseudogenes in different inbred strains of mice. Genomics (1992) 0.82
Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components. Neoplasia (1999) 0.81
Cytogenetic and molecular analysis in Philadelphia negative CML. Blood (1989) 0.81
Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes. Leukemia (1995) 0.81
Tel induces a G1 arrest and suppresses Ras-induced transformation. Oncogene (2000) 0.81
The human c-abl oncogene in the Philadelphia translocation. J Cell Physiol Suppl (1984) 0.80
The rat androgen receptor gene promoter. Mol Cell Endocrinol (1990) 0.80
TEL Induces Aggregation in Transformed Cells and Induces Tube Formation in NIH3T3-UCLA Cells. Biochem Biophys Res Commun (2002) 0.80
Halomonas magadii sp. nov., a new member of the genus Halomonas, isolated from a soda lake of the East African Rift Valley. Extremophiles (2000) 0.80
Chronic myelogenous leukemia: biology and therapy. Leukemia (1993) 0.79
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia (1997) 0.79
Immunologic characterization of the tumor-specific bcr-abl junction in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood (1990) 0.79
Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis. Leuk Res (1986) 0.79
Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies. Genes Chromosomes Cancer (1998) 0.79